Skip to main content

Advertisement

Table 2 Characteristics of the study population, by ethnicity

From: A feasibility study to assess the validity of administrative data sources and self-reported information of breast cancer survivors

Characteristic Breast cancer patients (n = 83, 100 %)a
Jewish women (n = 54, 65.1 %) Arab women (n = 29, 34.9 %)
Demographics
 Age at breast cancer diagnosis
   ≤ 39 years 2 (3.7) 8 (27.6)
  40–49 years 13 (24.1) 8 (27.6)
  50–59 years 21 (38.9) 8 (27.6)
   ≥ 60 years 18 (33.3) 5 (17.2)
 Cohabitation status
  Married/living with a spouse 27 (50.0) 15 (51.7)
  Unmarriedb 18 (33.3) 7 (24.1)
  Missingc 9 (16.7) 7 (24.1)
  Education, meand (SD), year 13.3 (3.1) 7.2 (4.8)
 Immigration status
  Yes (country birth not Israel) 34 (63.0) 1 (3.4)
  No (country birth Israel) 11 (20.4) 21 (72.4)
  Missing 9 (16.7) 7 (24.1)
 Parity
  0 2 (3.7) 3 (10.3)
  1 12 (22.2) 0 (0.0)
  2 16 (29.6) 2 (6.9)
  3 9 (16.7) 2 (6.9)
   ≥ 4 6 (11.1) 15 (51.7)
  Missing 9 (16.7) 7 (24.1)
Breast cancer treatment and related effects
 Breast cancer diagnosis year
  2003–2005 21 (38.9) 8 (27.6)
  2006–2008 18 (33.3) 12 (41.4)
  2009–2010 15 (27.8) 9 (31.0)
 Treatments
  Breast conserving 41 (75.9) 18 (62.1)
  Mastectomy 12 (22.2) 10 (34.5)
  Axillary lymph node dissection 32 (59.3) 21 (72.4)
  Radiotherapy 48 (88.9) 27 (93.1)
  Chemotherapye 28 (51.9) 23 (79.3)
  Hormone therapyf 41 (75.9) 20 (69.0)
 Employment transition following diagnosis/treatment
  No change 25 (46.3) 17 (58.6)
  Upgraded 1 (1.9) 0 (0.0)
  Downgraded 19 (35.2) 5 (17.2)
  Missing 9 (16.7) 7 (24.1)
 Income change following diagnosis/treatment
  No change 26 (48.2) 17 (58.6)
  Increased 0 (0.0) 1 (3.5)
  Decreased 19 (35.2) 4 (13.8)
  Missing 9 (16.7) 7 (24.1)
 Weight change following diagnosis/treatment
  No change 15 (27.8) 8 (27.6)
  Increased 16 (29.6) 11 (37.9)
  Decreased 13 (24.1) 3 (10.3)
  Don’t know 1 (1.9) 0 (0.0)
  Missing 9 (16.7) 7 (24.1)
 Chronic pain related to breast cancer
  Yes 31 (57.4) 19 (65.5)
  No 14 (25.9) 3 (10.3)
  Missing 9 (16.7) 7 (24.1)
 Chronic pain intensity
  0 (no pain) 14 (25.9) 3 (10.3)
  1–3 (light pain) 5 (9.3) 3 (10.3)
  4–7 (moderate pain) 26 (48.2) 10 (34.5)
  8–10 (severe pain) 0 (0.0) 6 (20.7)
  Missing 9 (16.7) 7 (24.1)
 Number of chronic pain locations
  0 14 (25.9) 3 (10.3)
  1–2 24 (44.4) 9 (31.0)
  3–4 7 (13.0) 10 (34.5)
  Missing 9 (16.7) 7 (24.1)
Lifestyles
 Tobacco use
  Current smoker 7 (13.0) 2 (6.9)
  Former smoker 7 (13.0) 1 (3.5)
  Never smoker 31 (57.4) 19 (65.5)
  Missing 9 (16.7) 7 (24.1)
 Physical activity
  Yes 33 (61.1) 13 (44.8)
  No 12 (22.2) 9 (31.0)
  Missing 9 (16.7) 7 (24.1)
 Daily servings of fruits and vegetables
  0 0 (0.0) 0 (0.0)
  1–2 28 (51.9) 18 (62.1)
   ≥ 3 17 (31.5) 4 (13.8)
  Missing 9 (16.7) 7 (24.1)
  BMI, mean (SD), kg/m2 27.4 (4.9) 29.5 (6.3)
  1. Abbreviations: SD standard deviation, BMI body mass index
  2. a 83 Eligible participants identified by both LHS and INCR records; of them 67 completed the survey questionnaire. Data are presented as No.(%) unless otherwise noted; percentages may not sum to 100 due to rounding
  3. b Unmarried category comprised of all women not married: divorced, separated, widowed, or single
  4. c Missing information refers to information elicited from questionnaires, since not all subjects were interviewed
  5. d Analysis of mean education did not include missing data of 16 subjects who were not interviewed
  6. e Chemotherapy comprised mainly of anthracycline or taxane-based combinations
  7. f Hormone therapy was based on aromatase inhibitors, anti-estrogens, or combinations